AnswersNow Raises $40M Series B to Scale AI-Enabled, BCBA-Led Virtual Autism Therapy

AnswersNow has closed a $40 million Series B funding round to expand its virtual Applied Behavioral Analysis (ABA) therapy platform, positioning the company to meet rising demand for more accessible and cost-effective autism care. The round was led by HealthQuest Capital, with participation from existing investors Left Lane Capital, Owl Ventures and others.

Based in Richmond, Virginia, AnswersNow has built a fully virtual ABA model that connects families directly with Board-Certified Behavioral Analysts (BCBAs) for personalised, one-to-one therapy sessions. The company claims its approach delivers clinically proven outcomes in roughly one-sixth the therapy hours required by traditional in-person ABA, generating substantial savings for commercial insurers and Medicaid plans while improving access for families.

Proceeds from the round will be used to aggressively scale the platform and clinical team. AnswersNow plans to double its BCBA workforce, make senior leadership hires, launch new service offerings, and continue investing in artificial intelligence to further personalise care delivery and improve efficiency.

At the core of the model is an AI-enabled platform that creates customised learning modules based on each child’s individual interests and engagement patterns. This allows BCBAs to continuously adapt therapy content, accelerating skills acquisition and improving generalisation to everyday settings.

“The data shows that by exclusively using Master’s- and PhD-level BCBAs for targeted parent training, in combination with our AI-enabled, focused therapy for children, we can achieve equal or better outcomes at a fraction of the time and cost,” said CEO Jeff Beck. “Our powerful care-delivery model makes proven autism therapy accessible for families and financially sustainable for payors.”

In 2025 alone, AnswersNow facilitated nearly 100,000 hours of virtual ABA therapy and caregiver training. Within six months on the platform, 96% of families reported meaningful improvements in behaviour and communication, while payors saw up to a 75% reduction in total autism care costs compared with traditional models. The company has also maintained a Net Promoter Score of 83.

HealthQuest Capital partner Sam Brasch framed the investment as a response to structural gaps in autism services. “The autism support system in America is broken, leaving families to wait months or longer for services at untenable costs for insurers,” he said. “AnswersNow’s virtual therapy model aims to deliver results in less time and with lower costs than traditional therapy.”

Looking ahead, AnswersNow plans to publish peer-reviewed research in early 2026 to formally document its outcomes and efficiency. With autism diagnoses continuing to rise and access constraints persisting nationwide, the company is positioning itself as a scalable alternative to traditional, labour-intensive ABA delivery models.

Click here for the original news story.